AI
ACRX. AcelRx Receives Notice of Eligibility for Centralized Review from European Medicines Agency for the Sufentanil NanoTab® PCA System
Centralized review process used for products that provide a significant therapeutic, scientific or technical innovation to patient health
http://finance.yahoo.com/news/acelrx-receives-notice-eligibility-centralized-113000549.html
Centralized review process used for products that provide a significant therapeutic, scientific or technical innovation to patient health
http://finance.yahoo.com/news/acelrx-receives-notice-eligibility-centralized-113000549.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
